Increasing Study Sensitivity Early in Trials; Applied Clinical Trials, April 2010; Shiffman, S.

Summary:  This peer-reviewed article demonstrates why eDiaries are important in Phase II clinical trials, delivering a greater ability to detect treatment effects and reducing the size and costs of drug development programs.  Multiple case studies are presented, outlining how researchers who have adopted ePRO methods early in clinical development have gained greater insight into the full therapeutic potential of their candidate drugs.

Download “Increasing Study Sensitivity Early in Trials” now